In the following prophylactic tumor study, azido-labeled DC vaccine coupled with DBCO-IL-15 resulted in slower tumor growth and prolonged animal survival, in comparison with DC + IL-15 or DC alone (Fig. 6g, h). The gene discussed is IL15; the disease is neoplasm.